Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Sequential Intensified Conditioning Regimen Allogeneic Transplantation in Younger Adult Patients with Adverse-Risk Acute Myeloid Leukemia: A Multi-Center Prospective Study from the Acute Leukemia French Intergroup on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Blood (2024) 144 (Supplement 1): 3483.

https://doi.org/10.1182/blood-2024-198603

Published: 2024

Journal Articles

Allogeneic Stem-Cell Transplantation for Relapsed/Refractory ALK-Positive Anaplastic Large-Cell Lymphoma: A Study from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Blood (2024) 144 (Supplement 1): 4946.

https://doi.org/10.1182/blood-2024-212055

Published: 2024

Journal Articles

A Phase 2 Study of Ponatinib for Prevention of Relapse after Allotransplantation in FLT3-ITD + AML Patients : The Ponallo Trial

Patrice Chevallier, Anne Thiebaut, Sylvie François, Sylvain Chantepie, Marie Thérèse Rubio, Hélène Labussière-Wallet, Eolia Brissot, Natacha Maillard, Anne Huynh, Valerie Coiteux, Alice Garnier, Amandine Le Bourgeois, Pierre Peterlin, Thierry Guillaume

Blood (2023) 142 (Supplement 1): 4957.

https://doi.org/10.1182/blood-2023-179734

Published: 2023

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Blood (2023) 142 (Supplement 1): 2235.

https://doi.org/10.1182/blood-2023-184383

Published: 2023

Journal Articles

Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time - a Study By the SFGM-TC

Blood (2023) 142 (Supplement 1): 4926.

https://doi.org/10.1182/blood-2023-184836

Published: 2023

Journal Articles

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Alexis Maillard, Rabah Redjoul, Marion Klemencie, Hélène Labussière Wallet, Amandine Le Bourgeois, Maud D'Aveni, Anne Huynh, Ana Berceanu, Tony Marchand, Sylvain Chantepie, Carmen Botella Garcia, Michael Loschi, Magalie Joris, Cristina Castilla-Llorente, Anne Thiebaut-Bertrand, Sylvie François, Mathieu Leclerc, Patrice Chevallier, Stephanie Nguyen

Blood (2022) 139 (1): 134–137.

https://doi.org/10.1182/blood.2021014232

Published: 2022

Includes: Supplemental data

Journal Articles

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients

Alexis Maillard, Rabah Redjoul, Marion Klemencie, Hélène Labussière, Amandine Le Bourgeois, Maud d'Aveni, Anna Berceanu, Sylvain Chantepie, Carmen Botella, Michael Loschi, Magalie Joris, Cristina Castilla-Llorente, Sylvie Francois, Mathieu Leclerc, Patrice Chevallier, Stephanie Nguyen Quoc

Blood (2021) 138 (Supplement 1): 336.

https://doi.org/10.1182/blood-2021-149495

Published: 2021

Journal Articles

Real Life Study on Allogeneic Hematopoietic Cell Transplantation Practice According to International Guidelines and Its Impact on Survival in Acute Myeloid Leukemia French Population

Blood (2021) 138 (Supplement 1): 4133.

https://doi.org/10.1182/blood-2021-152571

Published: 2021

Journal Articles

Mesenchymal Stromal Cell (MSC) Compassionate Use in France in Treatment of Steroid-Refractory Graft-Versus-Host-Disease (GVHD) after Approval By the Expert Committee of Société Française De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Lea Bosdure, Resident, Laurence Blanc, MD, Nimrod Buchbinder, MD, Valerie Coiteux, MD, Gaelle Fossard, MD, Sylvie Francois, MD, Marie Ouachee, MD, Catherine Paillard, MD PhD, Cecile Pochon, MD, Arthur Sterin, MD MSc, Nadine Petitpain, PharmD, Jacques-Olivier Bay, MD PhD, Marie Thérèse Rubio, MD PhD, Danièle Bensoussan, Jean-Hugues Dalle, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142304

Published: 2020

Journal Articles

Congenital Neutropenia Is Also Associated with a High Cancer Risk: A Study from the French Severe Chronic Neutropenia Registry

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136053

Published: 2020

Journal Articles

Impact of Donor Search Strategy for Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical or Matched Unrelated Donor for Patients Older Than 55 Years with Hematological Malignancies: Randomized Prospective Phase III Study

Samia Harbi, jean Marie Boher, Edouard Forcade, MD, Patrice Chevallier, MD PhD, Peffault De Latour Régis, Florent Malard, MDPhD, Sylvie Francois, MD, Amandine Charbonnier, MD, Eric Hermet, MD, Claude-Eric Bulabois, MD, Anne Huynh, Ana Berceanu, MD, Thomas Cluzeau, MDPhD, Marie Thérèse Rubio, MD PhD, Sabine Furst, Mohamad Mohty, MD PhD, Raynier Devillier, Didier Blaise, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-139440

Published: 2020

Journal Articles

Citrulline Trajectory during Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated to Conditioning Intensity and Non-Relapse Mortality

Christopher Nunes Gomes, Valerie Seegers, MD, Aline Schmidt, MDPhD, Corentin Orvain, MD PhD, Alban Villate, MD, Anne Bouvier, MDPhD, Gille Simard, MD, Aurélien Sutra Del Galy, MD, Sylvie Francois, MD, Aurelien Giltat, MD, Jean Baptiste Robin, MD, Yves Delneste, PhD, Norbert Ifrah, MDPhD, Mathilde Hunault, MDPhD, Sylvain Thepot, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-141390

Published: 2020

Journal Articles

Values of Hematopoietic Cell Transplantation-Specific Comorbidity Index, Comorbidity/Age Index and Augmented Comorbidity/Age Index in Recipients of Haploidentical Stem Cell Transplantation Using Ptcy As Gvhd Prophylaxis: A Retrospective Study of 223 Cases

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-138656

Published: 2020

Journal Articles

Prophylactic or Preemptive Low-Dose Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Prevent Disease Relapse Following Allogeneic Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Thierry Guillaume, MD PhD, Pierre Peterlin, Sylvain Thepot, MD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Sylvie François, MD, Corentin Orvain, Yannick Le Bris, PharmD, Clémentine Fronteau, PharmD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 4555.

https://doi.org/10.1182/blood-2019-123402

Published: 2019

Journal Articles

RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention - Final Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO - SFGM-TC French intergroup)

Blood (2017) 130 (Supplement 1): 4599.

https://doi.org/10.1182/blood.V130.Suppl_1.4599.4599

Published: 2017

Journal Articles

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Florent Malard, MDPhD, Myriam Labopin, MD PhD, Christina Cho, MD, Didier Blaise, Esperanza B. Papadopoulos, MD, Jakob R. Passweg, MDMS, Richard O'Reilly, MD, Noel Milpied, Molly Maloy, MS, Liisa Volin, H.R. Castro-Malaspina, MD, Yosr Hicheri, Ann A. Jakubowski, MD PhD, Sylvie François, Sergio A. Giralt, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 4564.

https://doi.org/10.1182/blood.V130.Suppl_1.4564.4564

Published: 2017

Journal Articles

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Amandine Le Bourgeois, PhD, Myriam Labopin, MD PhD, Sebastien Maury, MD PhD, Regis Peffault De Latour, MD PhD, Jean-Henri Bourhis, Patrice Ceballos, MD, Sylvie François, Karin Bilger, Didier Blaise, Thierry Guillaume, MD PhD, Mohamad Mohty, MD PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 1952.

https://doi.org/10.1182/blood.V130.Suppl_1.1952.1952

Published: 2017

Journal Articles

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Blood (2017) 129 (10): 1380–1388.

https://doi.org/10.1182/blood-2016-09-738385

Published: 2017

Includes: Supplemental data

Journal Articles

Outcome Analysis of High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation in Patients with Hodgkin Lymphoma: A Francophone Society of Bone Marrow Transplantation and Cellular Therapy Study

Blood (2016) 128 (22): 3458.

https://doi.org/10.1182/blood.V128.22.3458.3458

Published: 2016

Journal Articles

Reduced-Intensity (FB2) Vs Reduced-Toxicity Myeloablative (FB3/FB4) Fludarabine/Busulfan Based Conditioning Regimens for Non-Hodgkin Lymphoma (NHL) Allografted Adult Patients: A Retrospective Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Blood (2016) 128 (22): 980.

https://doi.org/10.1182/blood.V128.22.980.980

Published: 2016

NARROW

Sequential Intensified Conditioning Regimen Allogeneic Transplantation in Younger Adult Patients with Adverse-Risk Acute Myeloid Leukemia: A Multi-Center Prospective Study from the Acute Leukemia French Intergroup on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Allogeneic Stem-Cell Transplantation for Relapsed/Refractory ALK-Positive Anaplastic Large-Cell Lymphoma: A Study from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

A Phase 2 Study of Ponatinib for Prevention of Relapse after Allotransplantation in FLT3-ITD + AML Patients : The Ponallo Trial

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time - a Study By the SFGM-TC

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients

Real Life Study on Allogeneic Hematopoietic Cell Transplantation Practice According to International Guidelines and Its Impact on Survival in Acute Myeloid Leukemia French Population

Mesenchymal Stromal Cell (MSC) Compassionate Use in France in Treatment of Steroid-Refractory Graft-Versus-Host-Disease (GVHD) after Approval By the Expert Committee of Société Française De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Congenital Neutropenia Is Also Associated with a High Cancer Risk: A Study from the French Severe Chronic Neutropenia Registry

Impact of Donor Search Strategy for Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical or Matched Unrelated Donor for Patients Older Than 55 Years with Hematological Malignancies: Randomized Prospective Phase III Study

Citrulline Trajectory during Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated to Conditioning Intensity and Non-Relapse Mortality

Values of Hematopoietic Cell Transplantation-Specific Comorbidity Index, Comorbidity/Age Index and Augmented Comorbidity/Age Index in Recipients of Haploidentical Stem Cell Transplantation Using Ptcy As Gvhd Prophylaxis: A Retrospective Study of 223 Cases

Prophylactic or Preemptive Low-Dose Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Prevent Disease Relapse Following Allogeneic Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention - Final Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO - SFGM-TC French intergroup)

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Outcome Analysis of High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation in Patients with Hodgkin Lymphoma: A Francophone Society of Bone Marrow Transplantation and Cellular Therapy Study

Reduced-Intensity (FB2) Vs Reduced-Toxicity Myeloablative (FB3/FB4) Fludarabine/Busulfan Based Conditioning Regimens for Non-Hodgkin Lymphoma (NHL) Allografted Adult Patients: A Retrospective Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only